Omnicell, Inc. Stock

Equities

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
28.18 USD +1.26% Intraday chart for Omnicell, Inc. +4.84% -25.11%
Sales 2024 * 1.06B Sales 2025 * 1.13B Capitalization 1.28B
Net income 2024 * -19M Net income 2025 * 8M EV / Sales 2024 * 1.25 x
Net Debt 2024 * 51.72M Net cash position 2025 * 9.8M EV / Sales 2025 * 1.12 x
P/E ratio 2024 *
-66.9 x
P/E ratio 2025 *
148 x
Employees 3,650
Yield 2024 *
-
Yield 2025 *
-
Free-Float 80.5%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.26%
1 week+4.84%
Current month-3.59%
1 month+0.90%
3 months-16.95%
6 months-25.98%
Current year-25.11%
More quotes
1 week
26.14
Extreme 26.14
28.30
1 month
26.14
Extreme 26.14
29.71
Current year
25.69
Extreme 25.69
38.15
1 year
25.69
Extreme 25.69
77.14
3 years
25.69
Extreme 25.69
187.29
5 years
25.69
Extreme 25.69
187.29
10 years
25.00
Extreme 25
187.29
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 92-08-31
Director of Finance/CFO - 23-05-31
Chief Administrative Officer - 21-03-31
Members of the board TitleAgeSince
Director/Board Member 68 12-12-31
Director/Board Member 68 13-12-31
Chief Executive Officer 66 92-08-31
More insiders
Date Price Change Volume
24-04-22 28.18 +1.26% 449,802
24-04-19 27.83 +2.13% 331,952
24-04-18 27.25 +3.73% 322,456
24-04-17 26.27 -1.43% 412,388
24-04-16 26.65 -0.86% 322,939

Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT

More quotes
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
27.83 USD
Average target price
33.29 USD
Spread / Average Target
+19.60%
Consensus